Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto study

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 1, 2007, Pages 49-56

  Mendes Lana, A ^a   Pena, G G ^a   Freitas, S N ^a   Lima, A A ^a   Nicolato, R L C ^a   Nascimento Neto, R M ^b   Machado Coelho, G L L ^a   Freitas, R N ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b Instituto de Hipertensão Arterial   (Brazil)

Author keywords

Apolipoprotein E polymorphism; Atherosclerosis; Brazilian population; Dyslipidemia; Lipids

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHOLESTEROL; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; BRAZIL; CONTROLLED STUDY; DNA ISOLATION; DYSLIPIDEMIA; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

EID: 33846268452     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2007000100007     Document Type: Article

References (36)

1. Simons LA. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 1986; 57: 5G-10G.
2. OPAS - Organización Panamericana de la Salud. Tendencias demográficas y de mortalidad an la región de las Américas, 1980-2000. Bol Epidemiol 2002; 23: 1-4.
3. Lahoz C, Mostaza JM. Genetic markers associated with ischemic heart disease. Med Clin 1999; 113: 463-470.
4. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 1997; 349: 241-244.
5. Lin WR, Wozniak MA, Esiri MM, Klenerman P, Itzhaki RF. Herpes virus in brain, apolipoprotein E4 and herpes labialis. Alzheimers Rep 1998; 173-178.
6. Lin WR, Wozniak MA, Esiri MM, Klenerman P, Itzhaki RF. Herpes simplex encephalitis: involvement of apolipoprotein E genotype. J Neurol Neurosurg Psychiatry 2001; 70: 117-119.
7. Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 1998; 4: 1182-1184.
8. Wozniak MA, Itzhaki RF, Faragher EB, James MW, Ryder SD, Irving WL. Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology 2002; 36: 456-463.
9. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-630.
10. Mahley RW, Ji ZS. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 1999; 40: 1-16.
11. Huang Y, Liu XQ, Rail SC Jr, Mahley RW. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins. J Biol Chem 1998; 273: 17483-17490.
12. Kesaniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987; 80: 578-581.
13. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991; 49: 338-349.
14. Gerdes LU, Klausen IC, Sihm I, Faergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations ground the world. Genet Epidemiol 1992; 9: 155-167.
15. Chanprasertyothin S, Ongphiphadhanakul B, Rajatanavin R, Piaseu N, Chailurkit LO, Puavilai G. Correlation of apolipoprotein E gene polymorphism to serum lipid concentrations in healthy Thais. J Med Assoc Thai 2000; 83: 1233-1239.
16. Gamboa R, Hernandez-Pacheco G, Hesiquio R, Zuniga J, Masso F, Montano LF, et al. Apolipoprotein E polymorphism in the Indian and Mestizo populations of Mexico. Hum Biol 2000; 72: 975-981.
17. Thelma BK, Juyall RC, Dodge HH, Pandav R, Chandra V, Ganguli M. APOE polymorphism in a rural older population-based sample in India. Hum Biol 2001; 73: 135-144.
18. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1-21.
19. Valveny N, Esteban E, Kandil M, Moral P. APO E polymorphism in Spanish and Moroccan populations. Clin Genet 1997; 51: 354-356.
20. Alves-Silva J, da Silva Santos M, Guimaraes; PE, Ferreira AC, Bandelt HJ, Pena SD, et al. The ancestry of Brazilian mtDNA lineages. Am J Hum Genet 2000; 67: 444-461.
21. Carvalho-Silva DR, Santos FR, Rocha J, Pena SD. The phylogeography of Brazilian Y-chromosome lineages. Am J Hum Genet 2001; 68: 281-286.
22. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci U S A 2003; 100: 177-182.
23. Abe-Sandes K, Silva WA Jr, Zago MA. Heterogeneity of the Y chromosome in Afro-Brazilian populations. Hum Biol 2004; 76: 77-86.
24. IBGE - Instituto Brasileiro de Geografia a Estatística. Contagem populacional. Brasília: IBGE; 1996.
25. World Health Organization. WHO Expert committee on physical Status: the use and interpretation of anthropometry physical status. Geneva: WHO Technical Report Series, Vol. 854; 1995.
26. Santos RD. III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 2001; 77 (Suppl 3): 1-48.
27. Mendes-Lana A. Estudo da associação dos polimorlismos da apolipoproteína E (APOE) com níveis de lipídios séricos e variáveis demográficas em indivíduos do município de Ouro Preto. (Master's thesis]. Ouro Preto: Núcleo de Pesquisas em Ciências Biológicas, Universidade Federal de Ouro Preto; 2005.
28. Emi M, Wu LL, Robertson MA, Myers RL, Hegele RA, Williams RR, et al. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988; 3: 373-379.
29. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31: 545-548.
30. Gerdes LU, Gerdes C, Hansen PS, Klausen IC, Faergeman O, Dyerberg J. The apolipoprotein E polymorphism in Greenland Inuit in its global perspective. Hum Genet 1996; 98: 546-550.
31. Lucotte G, Loirat F, Hazout S. Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe. Hum Biol 1997; 69: 253-262.
32. Sepehrnia B, Kamboh MI, Adams-Campbell LL, Bunker CH, Nwankwo M, Majumder PP, et al. Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. Am J Hum Genet 1989; 45: 586-591.
33. Zekraoui L, Lagarde JP, Raisonnier A, Gerard N, Aouizerate A, Lucotte G. High frequency of the apolipoprotein E *4 allele in African pygmies and most of the African populations in sub-Saharan Africa. Hum Biol 1997; 69: 575-581.
34. de-Andrade FM, Larrandaburu M, Callegari-Jacques SM, Gastaldo G, Hutz MH. Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a Southern Brazilian population. Braz J Med Biol Res 2000; 33: 629-537.
35. Schwanke CH, Da Cruz I, Leal NF, Scheibe R, Moriguchi Y, Moriguchi EH. Analysis of the association between apolipoprotein E polymorphism and cardiovascular risk factors in an elderly population with longevity. Arq Bras Cardiol 2002; 78: 561-579.
36. de Franca E, Alves JG, Hutz MH. Apolipoprotein E polymorphism and its association with serum lipid levels in Brazilian children. Hum Biol 2004; 76: 267-275.